| Quarter | Score |
|---|---|
| 2013-Q2 | 49.5 |
| 2013-Q3 | 52.0 |
| 2013-Q4 | 48.0 |
| 2014-Q1 | 51.2 |
| 2014-Q2 | 48.3 |
| 2014-Q3 | 49.8 |
| 2018-Q1 | 49.9 |
| 2018-Q2 | 50.6 |
| 2018-Q3 | 48.6 |
| 2019-Q2 | 48.2 |
| 2022-Q1 | 50.2 |
| 2022-Q3 | 65.5 |
| 2022-Q4 | 46.4 |
| 2023-Q1 | 64.1 |
| 2023-Q2 | 44.3 |
| 2023-Q3 | 49.9 |
| 2023-Q4 | 54.0 |
| 2024-Q1 | 59.9 |
| 2024-Q2 | 74.1 |
| 2024-Q3 | 73.6 |
| 2024-Q4 | 72.6 |
| 2025-Q1 | 74.0 |
| 2025-Q2 | 69.7 |
| 2025-Q3 | 68.7 |
| 2025-Q4 | 90.7 |
High consensus with active accumulation at an attractive valuation
No price reference available to measure drift vs fund cost basis
0 of 16 tracked funds hold THC. Net holding.
Insufficient data for price analysis
No current holders
New to consensus — no prior quarter to compare
Too early to measure — check back next quarter
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 16 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|